Zenith Laboratories Inc said theFood and Drug Administration approved Cephradine, anantibiotic, for marketing.    The maker of generic drugs, less costly versions of brandname drugs that have lost their patents, said Cephradine hasbeen available as Velosef from Squibb Corp &lt;SQB> and Ansporfrom a SmithKline Beckman Corp &lt;SKB> unit.    Earlier this week the company said it received FDAmarketing approval for Cefadroxil, another antibiotic, which itsaid it will market once questions "relating to patentapplicability are resolved." Reuter&#3;